Novel therapeutic
for spinal cord
injury
License Opportunity 270
Inhibition of Nogo signalling using a protein-based therapeutic
to promote neurite outgrowth and regeneration of the CNS
Novel protein-based therapeutic approach for spinal cord injury
using protein kinase A and/or casein kinase II
Use of protein to extracellularly phosphorylate the Nogo receptor to
alleviate inhibition of neurite growth
Demonstrated in vivo with restoration of mobility within 2 weeks
High un-met medical need for spinal cord injury therapeutics with
low μM detection limits
